A new class of drugs against MRSA

A new way of treating MRSA

Antibiotic resistance is rising to dangerously high levels. Therefore, we must rethink existing standards and develop new solutions.

ANTIBIOTICS

Louis Pasteur coined the phrase "life prevents life" after discovering in 1877 that some types of bacteria inhibit each other's growth.

PENICILLIN

Alexander Fleming began in 1928 with a forgotten and moldy staphylococcus culture at St. Mary's Hospital in London.

RESISTANCE

Due to the irresponsible use of antibiotics, resistance to almost all antibiotics has developed worldwide.

BACTERIOPHAGEN

To help this ever-growing group of patients, we rely on the use of highly effective bacteriophages.

Overview

The pharmaceutical industry worldwide

1.162

billion Global revenue

40

billion US dollars are spent annually on antibiotics

15

Years it takes from research to the use of an antibiotic

400

billion US dollars are jointly contributed by the EU and the US to promote research into antibiotics against multi-resistant bacteria

98

billion US dollars are the total marketing costs of the ten largest pharmaceutical companies

89.8

Total annual profits of the ten largest pharmaceutical companies

Investment Highlights

Innovative technology with high upside

Icon

Innovative business model

Billions of US dollars are spent annually on antibiotics

Icon

Future-proof positioning

The development approach strongly addresses the ever-growing problem of antibiotic resistance

Icon

High upside through further developments

The first prototype can be used to identify further bacterial infections, enabling the use of new bacteriophages Coming soon

Icon

Recurring revenues after rollout

By licensing the developed bacteriophages, long-term recurring revenues can be generated.